| The target landscape of clinical kinase drugs S Klaeger, S Heinzlmeir, M Wilhelm, H Polzer, B Vick, PA Koenig, ... Science 358 (6367), eaan4368, 2017 | 736 | 2017 |
| Reorganization of enhancer patterns in transition from naive to primed pluripotency C Buecker, R Srinivasan, Z Wu, E Calo, D Acampora, T Faial, A Simeone, ... Cell stem cell 14 (6), 838-853, 2014 | 478 | 2014 |
| Integrative proteomic characterization of human lung adenocarcinoma JY Xu, C Zhang, X Wang, L Zhai, Y Ma, Y Mao, K Qian, C Sun, Z Liu, ... Cell 182 (1), 245-261. e17, 2020 | 348 | 2020 |
| Global proteome analysis of the NCI-60 cell line panel AM Gholami, H Hahne, Z Wu, FJ Auer, C Meng, M Wilhelm, B Kuster Cell reports 4 (3), 609-620, 2013 | 339 | 2013 |
| Optimized chemical proteomics assay for kinase inhibitor profiling G Médard, F Pachl, B Ruprecht, S Klaeger, S Heinzlmeir, D Helm, H Qiao, ... Journal of proteome research 14 (3), 1574-1586, 2015 | 136 | 2015 |
| Systematic identification of the HSP90 regulated proteome Z Wu, AM Gholami, B Kuster Molecular & cellular proteomics 11 (6), 2012 | 120 | 2012 |
| Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer Z Wu, JB Doondeea, AM Gholami, MC Janning, S Lemeer, K Kramer, ... Molecular & Cellular Proteomics 10 (12), 2011 | 94 | 2011 |
| Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1 S Lemeer, A Bluwstein, Z Wu, J Leberfinger, K Müller, K Kramer, B Kuster Journal of proteomics 75 (12), 3465-3477, 2012 | 81 | 2012 |
| A chemical proteomics approach for global analysis of lysine monomethylome profiling Z Wu, Z Cheng, M Sun, X Wan, P Liu, T He, M Tan, Y Zhao Molecular & Cellular Proteomics 14 (2), 329-339, 2015 | 74 | 2015 |
| JX06 selectively inhibits pyruvate dehydrogenase kinase PDK1 by a covalent cysteine modification W Sun, Z Xie, Y Liu, D Zhao, Z Wu, D Zhang, H Lv, S Tang, N Jin, H Jiang, ... Cancer research 75 (22), 4923-4936, 2015 | 73 | 2015 |
| Arabidopsis SH3P2 is an ubiquitin-binding protein that functions together with ESCRT-I and the deubiquitylating enzyme AMSH3 MK Nagel, K Kalinowska, K Vogel, GD Reynolds, Z Wu, F Anzenberger, ... Proceedings of the National Academy of Sciences 114 (34), E7197-E7204, 2017 | 71 | 2017 |
| Characterization of Protein Lysine Propionylation in Escherichia coli: Global Profiling, Dynamic Change, and Enzymatic Regulation M Sun, J Xu, Z Wu, L Zhai, C Liu, Z Cheng, G Xu, S Tao, BC Ye, Y Zhao, ... Journal of proteome research 15 (12), 4696-4708, 2016 | 51 | 2016 |
| Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma Y Wang, K Chen, Y Cai, Y Cai, X Yuan, L Wang, Z Wu, Y Wu Journal of Experimental & Clinical Cancer Research 36, 1-16, 2017 | 45 | 2017 |
| The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation Y Gu, F Lv, M Xue, K Chen, C Cheng, X Ding, M Jin, G Xu, Y Zhang, Z Wu, ... Journal of Experimental & Clinical Cancer Research 37, 1-14, 2018 | 36 | 2018 |
| SAHA regulates histone acetylation, butyrylation, and protein expression in neuroblastoma G Xu, J Wang, Z Wu, L Qian, L Dai, X Wan, M Tan, Y Zhao, Y Wu Journal of proteome research 13 (10), 4211-4219, 2014 | 36 | 2014 |
| Aberrant expression of FBXO2 disrupts glucose homeostasis through ubiquitin-mediated degradation of insulin receptor in obese mice B Liu, H Lu, D Li, X Xiong, L Gao, Z Wu, Y Lu Diabetes 66 (3), 689-698, 2017 | 35 | 2017 |
| Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma WJ Wu, J Shi, G Hu, X Yu, H Lu, ML Yang, B Liu, ZX Wu Tumor Biology 37, 6045-6051, 2016 | 29 | 2016 |
| Comprehensive profiling of lysine acetylome in Staphylococcus aureus Y Zhang, ZX Wu, XL Wan, P Liu, JB Zhang, Y Ye, YM Zhao, MJ Tan Science China Chemistry 57, 732-738, 2014 | 25 | 2014 |
| Phosphoproteomics reveals ALK promote cell progress via RAS/JNK pathway in neuroblastoma K Chen, F Lv, G Xu, M Zhang, Y Wu, Z Wu Oncotarget 7 (46), 75968, 2016 | 19 | 2016 |
| Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species‑mediated apoptosis by targeting the electron transport chain L Pan, L Nie, S Yao, A Bi, Y Ye, Y Wu, Z Tan, Z Wu International journal of molecular medicine 46 (6), 2137-2149, 2020 | 18 | 2020 |
